We have received funding by means of sponsorship from multiple pharmaceutical companies and MedTech industries to support the delivery of our national conference. Our sponsors have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.
About A. Menarini Farmaceutica Internazionale SRL
A. Menarini Farmaceutica Internazionale SRL is the UK subsidiary of the Menarini group which is present in 140 countries worldwide, headquartered in Florence. We work to partner with the NHS, identifying opportunities where our products can make a real difference to patients’ lives in both primary and secondary care. Menarini Group has been supporting people living with diabetes for over 30 years.
For more information please visit: www.menarinipro.co.uk
About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.
At Abbott, we believe people with diabetes should enjoy active lives, so we’re focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology is revolutionising how people monitor glucose and providing healthcare professionals with more data to make better informed treatment decisions.
About Lilly
Lilly is a medicine company turning science into therapies to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world’s most significant health challenges.
We have been a global leader in diabetes since 1923, and are redefining diabetes and obesity care today. Through research, medicines, technologies, support programs and more, we strive to make life better for people living with diabetes and obesity
To learn more, visit www.lilly.com/uk or www.linkedin.com/showcase/eli-lilly-and-company-uk-and-ireland/
Lilly has only provided sponsorship for the delivery of the conference and have only had input into the symposia sessions which they have sponsored.
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its medicines are used by millions of patients worldwide.
With a proud 100-year heritage in advancing UK science, today AstraZeneca is the UK’s leading biopharmaceutical company. The company is based in five different locations across the UK, with its global headquarters in Cambridge. In the UK, around 8,700 employees work in research and development, manufacturing, supply, sales, and marketing. We supply around 36 different medicines to the NHS.
For more information, please visit www.astrazeneca.co.uk and follow us on Twitter @AstraZenecaUK.
About Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow.
Learn more at www.boehringer-ingelheim.com/uk
About Novo Nordisk
Novo Nordisk has provided sponsorship to TREND Diabetes Ltd. to support the delivery of the national conference. Novo Nordisk has had no influence over the agenda, content development, choice of speakers or meeting arrangements. Novo Nordisk has been granted stand space and will be present at the conference.
Learn more at www.novonordisk.co.uk/
Novo Nordisk has provided sponsorship to Trend Diabetes to cover the cost of stand space for this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements.
About Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and potentially life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.
For more information visit: www.sanofi.co.uk